Blood-Cleansing device shows promise for dangerous pregnancy condition
NCT ID NCT02923206
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a medical device that filters a harmful protein called sFlt-1 from the blood of pregnant women with preeclampsia, a serious condition causing high blood pressure. The goal was to see if the treatment is safe and can help control the disease. The trial involved 21 participants and focused on safety for both mother and baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cambridge Clinical Trials Unit, Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
Oxford, OX3 9DU, United Kingdom
-
Universitätsklinikum Köln
Cologne, 50937, Germany
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a placental protein unlock the mystery of preeclampsia?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Vitamin d may cut risk of repeat preeclampsia in High-Risk pregnancies
- Depression drug may mend blood vessels damaged by preeclampsia
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Genetic clues to severe preeclampsia could transform early detection